BNGO — BioNano Genomics Balance Sheet
0.000.00%
Last trade - 00:00
- $39.22m
- -$23.70m
- $36.12m
- 28
- 60
- 17
- 27
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17.3 | 38.4 | 251 | 113 | 66.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.33 | 2.77 | 5.32 | 7.5 | 9.66 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 28.3 | 46.8 | 272 | 157 | 140 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.95 | 4.91 | 20.9 | 29 | 32.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 30.2 | 60.5 | 377 | 308 | 214 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 26.4 | 8.95 | 21.8 | 35.9 | 100 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 26.6 | 25.4 | 40 | 58.1 | 118 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3.61 | 35.1 | 337 | 249 | 96.2 |
Total Liabilities & Shareholders' Equity | 30.2 | 60.5 | 377 | 308 | 214 |
Total Common Shares Outstanding |